Based on current clinical evidence, the rough ordering from largest to smallest weight-loss effect is: Tirzepatide highest average weight loss Semaglutide significant weight loss Tesamorelin moderate weight loss, primarily through visceral fat reduction AOD-9604 primarily body composition effects MOTS-c primarily metabolic and energy effects rather than pure weight reduction AOD-9604 and MOTS-c are generally not considered replacements for GLP-1 medications in patients seeking substantial weight reduction

Praise for Becky Dorner & Associates Using Mindfulness to Deepen Your Intuitive Eating Practice Janice Baker, MBA, RDN, CDCES, CNSC, BC-ADM Using a Whole-Foods, Plant-Based Eating Pattern to Support Disease Management Course Amy Hess-Fischl, MS, RDN, LDN, BC-ADM, CDCES Ethics in Action: Applying the Academy Code of Ethics Doreen Rodo, MEd, RDN, LD Low-Fat Vegan Diet and Metabolic Health in Overweight Adults Lori Stevens, RD, LDN Kathleen Pellechia, MS, RDN Mastering Diabetes Management in Primary Care: Case Based Insights Course Amy Hess-Fischl, MS, RDN, LDN, BC-ADM, CDCES
Peptides may act differently than anabolic steroids, but they are not risk-free
Using a random-effects model, the pooled weighted mean difference (WMD) was computed